Doctor of Osteopathy Program year 2023 Reported 2022–2023 Source: CMS Open Payments, 2026 publication

Kelsie Carrier

Neuromuscular Medicine Delray Beach, FL Doctor of Osteopathy

NPI 1396309753 CMS profile 11388659

16244 S Military Trl Ste 450, Delray Beach, FL 33484

Open in the dashboard

General payments

$54

3 records reported · program years 2022–2023

Research payments

$0

Paid to them · None reported · program years 2022–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Kelsie Carrier of Delray Beach, FL is reported in the CMS Open Payments database as having received $54 across 3 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $19 1
2022 General $35 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kelsie Carrier
  • Neuromuscular Medicine median
  • Middle half of Neuromuscular Medicine
  • National median

In program year 2025, general payments to Kelsie Carrier were reported at $0. Among 29 Neuromuscular Medicine profiles paid that year, the median was $140 and the middle half received between $45 and $721.

Show as a table
Year Kelsie Carrier Neuromuscular Medicine median Middle half National median
2019 $0 $106 $32–$174 $163
2020 $0 — — $114
2021 $0 $142 $72–$2,438 $132
2022 $35 $146 $37–$459 $149
2023 $19 $125 $25–$296 $160
2024 $0 $182 $50–$398 $164
2025 $0 $140 $45–$721 $169

Breakdown

Who paid General payments · program years 2022–2023
  1. AbbVie, Inc. $37 2 payments
  2. Kowa Pharmaceuticals America, Inc. $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2023
  1. Food and Beverage $54 3 payments
Products named General payments · program years 2022–2023
  1. BOTOX Neuroscience $19 1 payment
  2. BOTOX Hyperhydrosis $18 1 payment
  3. Seglentis $17 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

17

Median for Osteopathic Manipulative Medicine: 311

Drug cost

$76

Median for Osteopathic Manipulative Medicine: $11,323

Branded share of claims

0%

Median for Osteopathic Manipulative Medicine: 19.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 17 $76

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 526 Part D prescribers listed as Osteopathic Manipulative Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 64 billing codes

Paid by Medicare

$258,085

Of which drugs: $1,674

Medicare patients

397

Average age 78

Services billed

4,403

259 women, 138 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 61%
Ischemic heart disease 46%
Chronic kidney disease 42%
Diabetes 39%
Alzheimer's or dementia 35%
Heart failure 32%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, ketorolac tromethamine, per 15 mg J1885 Office 42 101 $46
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 24 389 $35

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

3 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neuromuscular Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record